LV remodeling is a common structural event following myocardial infarction (MI), which can lead to congestive heart failure (CHF). Enzyme systems responsible for extracellular remodeling, particularly following MI, include the matrix metalloproteinases (MMPs). Pharmacological MMP inhibition can attenuate the LV remodeling process in animal models of CHF and post-MI. However, it has also been demonstrated that activation of certain MMP species may be an essential component of the initial wound healing process post-Ml. Recent results from our laboratory have demonstrated region specific induction of myocardial MMPs as well as a loss of endogenous inhibitors of MMPs (TIMPs) occurs post-Ml. Therefore the induction and activation of myocardial MMPs post-MI appears to occur in a species specific, region, and time dependent fashion. Since alterations in MMPs and TIMPs likely contribute to the remodeling process post-MI, then identifying the upstream signaling pathways which regulate MMP/TIMP induction and activation holds significant relevance. The bioactive peptide endothelin (ET) induces MMP expression in both myocytes and cardiac fibroblasts. Increased myocardial synthesis and release of ET occurs during and following MI and has been demonstrated to contribute to the progression of CHF. However, recent studies have demonstrated that initiation of ET receptor blockade early post-MI may actually accelerate infarct expansion and LV dysfunction. In contrast, ET receptor blockade initiated later in the post-MI period has been demonstrated to favorably modify the LV remodeling process, improve LV function and survival. The central hypothesis of this continuing project is that a time and region specific induction of myocardial MMPs occur post-MI which is under significant regulation of the ET system. This project will perform an integrative series of studies using a model of post-MI remodeling, murine systems of MI and ET induction, as well as in-vitro cell systems in order to identify how ET receptor activation contributes to early and late post-MI remodeling and therefore the progression to CHF. ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL057952-08
Application #
7149119
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Program Officer
Adhikari, Bishow B
Project Start
1998-01-01
Project End
2008-07-30
Budget Start
2006-12-01
Budget End
2008-07-30
Support Year
8
Fiscal Year
2007
Total Cost
$207,651
Indirect Cost
Name
Medical University of South Carolina
Department
Surgery
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Gopinathannair, Rakesh; Etheridge, Susan P; Marchlinski, Francis E et al. (2015) Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management. J Am Coll Cardiol 66:1714-28
Eckhouse, Shaina R; Purcell, Brendan P; McGarvey, Jeremy R et al. (2014) Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction. Sci Transl Med 6:223ra21
Graham, Eric M; Atz, Andrew M; McHugh, Kimberly E et al. (2014) Preoperative steroid treatment does not improve markers of inflammation after cardiac surgery in neonates: results from a randomized trial. J Thorac Cardiovasc Surg 147:902-8
Kholmukhamedov, Andaleb; Logdon, Christina; Hu, Jiangting et al. (2014) Cyclosporin A in left ventricular remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol 306:H53-9
Zavadzkas, Juozas A; Stroud, Robert E; Bouges, Shenikqua et al. (2014) Targeted overexpression of tissue inhibitor of matrix metalloproteinase-4 modifies post-myocardial infarction remodeling in mice. Circ Res 114:1435-45
Zile, Michael R; Baicu, Catalin F; Stroud, Robert E et al. (2014) Mechanistic relationship between membrane type-1 matrix metalloproteinase and the myocardial response to pressure overload. Circ Heart Fail 7:340-50
Spinale, Francis G; Stolen, Craig M (2013) Biomarkers and heart disease: what is translational success? J Cardiovasc Transl Res 6:447-8
Spinale, Francis G; Janicki, Joseph S; Zile, Michael R (2013) Membrane-associated matrix proteolysis and heart failure. Circ Res 112:195-208
Eckhouse, Shaina R; Jones, Jeffrey A; Spinale, Francis G (2013) Gene targeting in ischemic heart disease and failure: translational and clinical studies. Biochem Pharmacol 85:1-11
Spinale, Francis G (2013) Epilysin (matrix metalloproteinase-28) joins the matrix metalloproteinase team on the field of postmyocardial infarction remodeling. Circ Res 112:579-82

Showing the most recent 10 out of 67 publications